"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes "

drug protocol number
GLIME_R_05809
drug sponsor
Sanofi
drug study
GLIMEPIRIDE-HOE490
drug trial site
KFSH
drug status
Terminated
drug phase